8/3/2021 6:51:35 AM
Bausch Health To Reduce Debt By $350 Mln Through Redemption Of Outstanding Senior Notes
8/2/2021 7:02:37 AM
Bausch Health Completes Sale Of Amoun Pharma To Abu-Dhabi Based ADQ
7/12/2021 7:03:42 AM
Bausch + Lomb Launches Biotrue Hydration Boost Lubricant Eye Drops And Biotrue® Micellar Eyelid Cleansing Wipes
7/7/2021 7:06:37 AM
Bausch + Lomb Completes Enrollment Of Second Phase 3 Study For NOV03
7/1/2021 7:14:38 AM
Bausch Health To Reduce Debt By $150 Mln Through Redemption Of Outstanding Senior Notes, Using Cash Generated From Ops.
6/23/2021 7:02:36 AM
Bausch + Lomb Unveils Expanded Parameters For Bausch + Lomb ULTRA Multifocal For Astigmatism Contact Lenses
6/22/2021 7:06:41 AM
Bausch Health Extends Tender Offer For Cash Tender Offer For Senior Secured Notes By One Business Day To June 22
6/21/2021 7:01:38 AM
Bausch Health Announces Robert Hale Resigns From Board Of Directors
6/8/2021 7:00:50 AM
Bausch + Lomb And Lochan Agree To Develop Next-Generation Of EyeTELLIGENCE Clinical Decision Support Software
6/2/2021 7:25:15 AM
Bausch Health And Clearside Biomedical Announce FDA Filing Acceptance For XIPERE; Assigns PDUFA Action Date Of Oct 30
5/27/2021 7:16:32 AM
Bausch Health To Reduce Debt By $100 Mln Using Cash Generated From Operations
5/24/2021 8:25:49 AM
Bausch Health Launches Offering Of $1.6 Bln Of New Senior Secured Notes Due 2028
5/24/2021 8:24:07 AM
Bausch Health Commences Cash Tender Offer For 7% Senior Secured Notes Due 2024
5/4/2021 7:23:54 AM
Bausch Health Companies Q1 Net Loss $610 Mln Vs. Net Loss $152 Mln Last Year
5/3/2021 7:14:34 AM
Bausch Health To Reduce Debt By $100 Mln Using Cash Generated From Operations
4/29/2021 7:29:44 AM
Bausch + Lomb To Present New Scientific Data And Analyses On Products And Pipeline Programs
4/16/2021 1:38:37 AM
Bausch Health And Nicox: VYZULTA 0.024% Gets Approval From Brazilian Health Regulatory Agency